Ultragenyx Pharmaceutical Total Assets

Ultragenyx Pharmaceutical (RARE) currently reports a total assets of $1.3B as of June 2026. That compares with $1.3B in the prior-year period — down 3.2% year over year. Use the charts on this page to explore Ultragenyx Pharmaceutical's total assets history and peer comparisons.

Ultragenyx Pharmaceutical's total assets decreased from $1.3B to $1.3B — a 3.2% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Ultragenyx Pharmaceutical reported $1.3B in total assets as of June 2026. That compares with $1.3B in the prior-year period — down 3.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $1.3B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Ultragenyx Pharmaceutical, and consider following RARE for alerts when major investors trade the stock.

Ultragenyx Pharmaceutical is classified in the Healthcare sector. On total assets, it currently shows $1.3B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RARE with unrelated industries.